Cocrystal Pharma Inc (COCP)

Cocrystal Pharma Inc Azioni (COCP) Dati Finanziari

Conto economico

Trimestrale

*Tutti i numeri sono espressi in milioni

Data di fine periodo	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31
Durata del periodo	3 mesi	3 mesi	3 mesi	3 mesi	3 mesi
Revenues	-	-	-	-	-
Operating Expenses	10.89% 4.158	4.666	4.443	4.339	5.111
Depreciation and Amortization	12.50% 0.035	0.04	0.053	0.047	0.049
Operating Income/Loss	10.89% -4.158	-4.666	-4.443	-4.339	-5.111
Nonoperating Income/Loss	0.00% 0.202	0.202	0.278	-	-0.078
Income/Loss From Continuing Operations Before Tax	11.38% -3.956	-4.464	-4.165	-4.166	-5.189
Income/Loss From Continuing Operations After Tax	11.38% -3.956	-4.464	-4.165	-4.166	-5.189
Net Income/Loss	11.38% -3.956	-4.464	-4.165	-4.166	-5.189
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	5,255% 10.17	0.19	10.15	10.06	8.143
Diluted Average Shares	5,255% 10.17	0.19	10.15	10.06	-0.956
Basic Earnings Per Share	11.36% -0.39	-0.44	-0.41	-0.41	-0.64
Diluted Earnings Per Share	11.36% -0.39	-0.44	-0.41	-0.41	-0.62
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-